Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University Hung Hom, Hong Kong.
Front Chem. 2015 Jul 23;3:44. doi: 10.3389/fchem.2015.00044. eCollection 2015.
Lysine methyltransferase which catalyze methylation of histone and non-histone proteins, play a crucial role in diverse biological processes and has emerged as a promising target for the development of various human diseases, including cancer, inflammation, and psychiatric disorders. However, inhibiting lysine methyltransferases selectively has presented many challenges to medicinal chemists. During the past decade, lysine methyltransferase inhibitors covering many different structural classes have been designed and developed. In this review, we describe the development of selective, small-molecule inhibitors of lysine methyltransferases with an emphasis on their discovery and chemical synthesis. We highlight the current state of lysine methyltransferase inhibitors and discuss future directions and opportunities for lysine methyltransferase inhibitor discovery.
赖氨酸甲基转移酶可催化组蛋白和非组蛋白的甲基化,在多种生物学过程中发挥着关键作用,已成为开发包括癌症、炎症和精神疾病在内的多种人类疾病的有前途的靶点。然而,选择性抑制赖氨酸甲基转移酶给药物化学家带来了许多挑战。在过去的十年中,已经设计和开发了涵盖许多不同结构类别的赖氨酸甲基转移酶抑制剂。在本文综述中,我们描述了选择性小分子赖氨酸甲基转移酶抑制剂的开发,重点介绍了它们的发现和化学合成。我们强调了赖氨酸甲基转移酶抑制剂的现状,并讨论了赖氨酸甲基转移酶抑制剂发现的未来方向和机会。